Otitis media: a review. 1977

V A Perriello, and R F Ford, and W C McLean, and Z G Schoeny, and M A Sande

We have presented recommendations for diagnosis and management of otitis media in children based on a comprehensive review of the pertinent medical literature. For an entity that is so common, there still remain amazingly large numbers of areas of controversy. We have also attempted to stress the importance of appropriate therapy and adequate followup as being very important in the management of otitis media. Newer concepts, particularly the use of the impedance bridge tympanogram, have been mentioned. With all the above background information in mind and with considerations for what is practical for the patient and the medical community, we would recommend the following as the acceptable minimal care for patients with otitis media. When the diagnosis of the acute otitis media is made on the basis of physical findings of myringitis, and/or middle ear fluid, and/or rupture of the tympanic membrane, the following treatment course is advisable: Neonates Culture of middle ear fluid if possible. Ampicillin 200 mg/kg/day intramuscularly. Gentamicin 3/5mg/kg/day intramuscularly. Hospitalize and treat until well and for minimum of seven days. Observe closely for meningitis and other infections and drug toxicity. These should be handled only by physicians experienced in dealing with patients in this age range. Appropriate work-up for septicemia should precede treatment. Switch to specific antibiotic when cultures and sensitivity available. Children. From 2 months to 6 years of age: Ampicillin 50mg/kg/day. Decongestant (if desired). Administer for ten days. Every patient with otorrhea, severe otitis and those not clinically well should be seen for followup ten to 14 days later. They should have a minimum of otologic evaluation including drum mobility. In persistent cases, audiometry and otologic referral are necessary. If patient is allergic to penicillin, erythromycin at 20mg/lb/day may be used. Trimethoprim sulfa may hold promise in the future. Tetracycline is never indicated in this age range because of side effects and high relapse rate secondary to resistant organisms. Patients above 6 years of age: Penicillin pheyoxymethyl 250 mg every six hours for ten days. Decongestant (if desired). Followup and penicillin allergy as above.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D010033 Otitis Media Inflammation of the MIDDLE EAR including the AUDITORY OSSICLES and the EUSTACHIAN TUBE. Middle Ear Inflammation,Inflammation, Middle Ear
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000233 Adenoidectomy Excision of the adenoids. (Dorland, 28th ed) Adenoidectomies
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001299 Audiometry The testing of the acuity of the sense of hearing to determine the thresholds of the lowest intensity levels at which an individual can hear a set of tones. The frequencies between 125 and 8000 Hz are used to test air conduction thresholds and the frequencies between 250 and 4000 Hz are used to test bone conduction thresholds. Audiometries
D014068 Tonsillectomy Surgical removal of a tonsil or tonsils. (Dorland, 28th ed) Tonsillectomies

Related Publications

V A Perriello, and R F Ford, and W C McLean, and Z G Schoeny, and M A Sande
January 1979, Acta oto-rhino-laryngologica Belgica,
V A Perriello, and R F Ford, and W C McLean, and Z G Schoeny, and M A Sande
January 1981, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery,
V A Perriello, and R F Ford, and W C McLean, and Z G Schoeny, and M A Sande
January 2006, International journal of pediatric otorhinolaryngology,
V A Perriello, and R F Ford, and W C McLean, and Z G Schoeny, and M A Sande
October 1995, Clinical pediatrics,
V A Perriello, and R F Ford, and W C McLean, and Z G Schoeny, and M A Sande
March 1991, The Annals of otology, rhinology, and laryngology,
V A Perriello, and R F Ford, and W C McLean, and Z G Schoeny, and M A Sande
September 2019, American family physician,
V A Perriello, and R F Ford, and W C McLean, and Z G Schoeny, and M A Sande
May 1995, International journal of pediatric otorhinolaryngology,
V A Perriello, and R F Ford, and W C McLean, and Z G Schoeny, and M A Sande
October 2003, Minerva pediatrica,
V A Perriello, and R F Ford, and W C McLean, and Z G Schoeny, and M A Sande
June 2011, Journal of chemotherapy (Florence, Italy),
V A Perriello, and R F Ford, and W C McLean, and Z G Schoeny, and M A Sande
October 2017, International journal of molecular sciences,
Copied contents to your clipboard!